Michiko Takahashi

Michiko Takahashi

Auto-generated profile, based on publicly available information

Michiko Takahashi

Department of Surgery, Kochi Medical School, Kochi University

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2008 in FEBS Letters
Verified
Journal Article
Open access
MTMichiko Takahashi
Michiko Takahashi
YTYutaka Takahashi
Yutaka Takahashi
KTKenichi Takahashi
Kenichi Takahashi
FZFyodor N. Zolotaryov
Fyodor N. Zolotaryov
KHKyoung Su Hong
Kyoung Su Hong
KCKazuo Chihara
Kazuo Chihara
To explore a novel adipokine, we screened adipocyte differentiation‐related gene and found that TIG2/chemerin was strongly induced during the adipocyte differentiation. Chemerin was secreted by the mature 3T3‐L1 adipocytes and expressed abundantly in adipose tissue in vivo as recently described. Intriguingly, the expression of chemerin was differently regulated in the liver and adipose tissue in db/db mice. In addition, serum chemerin concentration was decreased in db/db mice. Chemerin and its receptor/ChemR23 were expressed in mature adipocytes, suggesting its function in autocrine/paracrine fashion. Finally, chemerin potentiated insulin‐stimulated glucose uptake concomitant with enhanced insulin signaling in the 3T3‐L1 adipocytes. These data establish that chemerin is a novel adipokine that regulates adipocyte function.

Verified
Journal Article
Open access
PDF file
HMHiromichi Maeda
Hiromichi Maeda
MTMichiko Takahashi
Michiko Takahashi
SSSatoru Seo
Satoru Seo
KHKazuhiro Hanazaki
Kazuhiro Hanazaki
Frailty is characterized by reduced physiological reserves across multiple systems. In patients with frailty, oncological surgery has been associated with a high rate of postoperative complications and worse overall survival. Further, given that cancer and frailty can co-exist in the same patient, cancer and cancer-related symptoms can rapidly accelerate the progression of baseline frailty, which we have termed “cancer frailty”. This distinction is clinically meaningful because the prioritization of interventions and the treatment outcomes may differ based on health conditions. Specifically, in patients with cancer frailty, improvements in frailty may be achieved via surgical removal of tumors, while prehabilitation may be less effective, which may in turn result in delayed treatment and cancer progression. In this review, we focused on challenges in the surgical treatment of non-metastatic colorectal cancers in patients with frailty, including those related to decision making, prehabilitation, and surgery. Potential recommendations for treating patients with cancer frailty are also discussed.

2 February 2004 in Soil Science and Plant Nutrition
Verified
Journal Article
Open access
TKTakanori Kobayashi
Takanori Kobayashi
YNYuko Nakayama
Yuko Nakayama
MTMichiko Takahashi
Michiko Takahashi
HIHaruhiko Inoue
Haruhiko Inoue
HNHiromi Nakanishi
Hiromi Nakanishi
NNNaoko K. Nishizawa
Naoko K. Nishizawa
Iron deficiency-responsive element 1 (IDE1) and IDE2 are cis-acting elements that are responsible for Fe-deficiency-inducible and root-specific expression of the barley (Hordeum vulgare L.) gene IDS2 (Fe-deficiency-specific clone no. 2). Using these cis-acting elements, we aimed to construct super-promoters that would induce prominent gene expression in the roots of Fe-deficient rice plants (Oryza sativa L.). Modules containing IDE1 and IDE2 of the IDS2 promoter were used as repeats or were linked to the Fe-deficiency-responsive promoter of barley IDS3, and were connected to known enhancer-like sequences. Five artificial promoters, as well as the native promoters of barley IDS2 or IDS3, were connected individually upstream of β-glucuronidase (GUS) and were introduced into rice. Transgenic rice plants were grown under control or Fe-deficient conditions, and GUS expression was analyzed. The artificial promoter that contained one module of IDE1 and IDE2 conferred strong Fe-deficiency-inducible GUS expression to the roots of rice plants. Each of the five artificial promoters induced a similar level of GUS expression in Fe-deficient roots, which did not exceed the GUS expression driven by the native IDS2 or IDS3 promoter. Artificial and native promoters induced GUS expression in response to Fe-deficiency in leaves, although the level of expression was lower than that in roots. Histochemical observations revealed that GUS expression driven by artificial and native promoters was spatially similar, and expression was dominant within vascular bundles and root exodermis. These findings suggest that there is coordinated expression of the genes that are involved in Fe-deficiency-induced Fe uptake in rice.

1 February 2018 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
MTMichiko Takahashi
Michiko Takahashi
YOYumiko Okakura
Yumiko Okakura
HTHiroki Takahashi
Hiroki Takahashi
MIMinami Imamura
Minami Imamura
ATAkira Takeuchi
Akira Takeuchi
BKBon Kimura
Bon Kimura

22 July 2014 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Open access
Tomoko NozoyeTomoko Nozoye
Tomoko Nozoye
SKSuyoen Kim
Suyoen Kim
YKYusuke Kakei
Yusuke Kakei
MTMichiko Takahashi
Michiko Takahashi
HNHiromi Nakanishi
Hiromi Nakanishi
NNNaoko K. Nishizawa
Naoko K. Nishizawa
Iron (Fe) is an essential nutrient in both plants and humans. Fe deficiency on calcareous soil with low Fe availability is a major agricultural problem. Nicotianamine (NA) is one of the Fe chelator in plants, which is involved in metal translocation into seeds, and serves as an antihypertensive substance in humans. In this study, soybean plants overexpressing the barley NA synthase 1 (HvNAS1) gene driven by the constitutive CaMV 35S promoter were produced using Agrobacterium-mediated transformation. The transgenic soybean showed no growth defect and grew normally. The NA content of transgenic soybean seeds was up to four-fold greater than that of non-transgenic (NT) soybean seeds. The level of HvNAS1 expression was positively correlated with the amount of NA, and a high concentration of NA was maintained in the seeds in succeeding generations. The Fe concentration was approximately two-fold greater in transgenic soybean seeds than in NT soybean seeds. Furthermore, the transgenic soybeans showed tolerance to low Fe availability in calcareous soil. Our results suggested that increasing the NA content in soybean seeds by the overexpression of HvNAS1 offers potential benefits for both human health and agricultural productivity. NA is plant Fe chelator and has antihypertensive effect in humans. HvNAS1 overexpressed soybean contains large amount of NA and Fe, and showed tolerance to Fe deficiency.

1 January 2002 in Endocrine Journal
Verified
Journal Article
Open access
PDF file
TTToshihiro Tajima
Toshihiro Tajima
YKYuichi Kobayashi
Yuichi Kobayashi
SAShuji Abe
Shuji Abe
MTMichiko Takahashi
Michiko Takahashi
MKMutsuko Konno
Mutsuko Konno
KFKenji Fujieda
Kenji Fujieda
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies